Our 2024 Longevity Clinics Survey is open with respondents from all over the world: Have you participated yet?
Beyond the beneficial data that our survey shares on diagnostic approaches: imaging, cardio, cognitive screening, etc., and interventions offered: peptides, stem cell therapy, PRP, IV therapies, etc., our current survey is delivering some really fascinating results:
- 67% pursue CMEs (Continuing Medical Education) in healthy longevity medicine.
- 21% won’t take on patients with serious existing health conditions.
- 59% think that longevity practice software tools are OK but need more work.
- 73% help clients identify or manage their biological vs chronological age, which means 27% do not.
But if you want to be on the inside track of questions like client demographics, commercial growth, profitability, client acquisition, do clinics have sufficient numbers of clients, etc., then, if you’re a longevity clinician/clinic, we need 15 minutes of your time to help complete the survey.
The findings from this survey will be presented at the upcoming Roundtable of Longevity Clinics, and as a ‘thank you’ for completing it, respondents will get:
Here’s the link and QR!
Oh, and the Bryan Johnson question was: Do you think Bryan Johnson contributes to (i.e. creates awareness) or hinders (i.e. subverts proper medicine) the progress of longevity medicine?
Don’t agree? Then do join the survey and contribute your opinion.
We have had some excellent comments from leading professionals in the field, and we want to hear what you have to say – we’re live for another two weeks, so please join the conversation!
* Prize Draw Terms and Conditions
1. Eligibility
This prize draw is open to qualified clinicians aged 18 years or over, excluding employees of First Longevity Ltd or their immediate families, agents, or any third party directly associated with the administration of the prize draw. By entering the prize draw, participants agree to be bound by these terms and conditions.
2. How to enter
Entry to the prize draw is free. Participants will be automatically entered when they complete the full survey provided by First Longevity Ltd. Only one entry per person is permitted. Multiple entries from the same person will be disqualified. The closing date for entries is 01 December 2024. Entries received after this time will not be accepted.
3. Prize
The prize is one ticket to the Longevity/Clinical Conference in Singapore on 27-28 February 2025. Travel, accommodation, and any other expenses associated with attending the conference are not included in the prize. The prize is non-exchangeable, non-transferable, and no cash alternative is offered. First Longevity Ltd reserves the right to replace the prize with an alternative of equal or higher value if circumstances beyond its control make it necessary to do so.
4. Winner selection and notification
The winner will be chosen by random draw supervised by an independent person within 14 days of the closing date. The winner will be notified by email (using details provided at entry) within 7 days of the draw. If the winner does not respond to the email within 14 days of notification, they will forfeit their prize, and First Longevity Ltd will select another winner at random. The decision of First Longevity Ltd regarding any aspect of the prize draw is final and binding and no correspondence will be entered into.
5. Data protection and publicity
First Longevity Ltd will only process personal information as set out in its Privacy Policy, which can be found at www.longevity.technology. The winner’s name and organization may be announced on First Longevity Ltd’s website and social media channels. If you object to any or all of your surname, organization, and winning entry being published or made available, please contact First Longevity Ltd.
6. General
First Longevity Ltd reserves the right to cancel, amend, or suspend the prize draw if necessary due to circumstances outside its control. The prize draw will be governed by English law and entrants to the prize draw submit to the jurisdiction of the English courts.
